Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Terumo launches new Azur system with hydrogel technology
Azur is claimed to be the only peripheral platinum coil embolization system with a hydrogel coating that expands when introduced into the bloodstream, delivering greater filling and mechanical
Azur is claimed to be the only peripheral platinum coil embolization system with a hydrogel coating that expands when introduced into the bloodstream, delivering greater filling and mechanical
The EnRhythm MRI SureScan pacing system consists of the dual-chamber EnRhythm MRI SureScan pacemaker and CapSureFix MRI SureScan pacing leads (Model 5086MRI). The pacemaker incorporates all diagnostic and
The agreement establishes Sleep Holdings as the exclusive sleep diagnostics provider for the Little River Healthcare System, which is currently comprised of five facilities in Rockdale, Cameron, and
The system is said to offer scientists an important and unique tool for drug discovery. The VenaFlux is simple to use, reduces costly layers of animal model studies,
VEL-0230 is a new chemical entity that has dual-acting properties, in that it both stimulates bone formation and inhibits bone loss. As part of the application, company plans
The Court’s final order also held the plan of arrangement to be fair and reasonable to Axcan shareholders. The transaction is expected to close in the first quarter
The potential treatment will utilize the company’s lead oncology product, SL052, with various immunotherapeutic agents. Research has shown that photodynamic therapy (PDT) can augment the therapeutic effects of
NPS is finalizing a protocol for the confirmatory Phase III study to address the FDA’s comments and incorporate results from the ongoing Phase III extension study that will
Under the terms of the signed agreement, Merck will lead and fund development and commercialization activities. SurModics will receive a licensing fee and payment for its development activities.
Ciclesonide, Nycomed’s proprietary corticosteroid, has a unique activation mechanism and is the active ingredient in Alvesco HFA (hydrofluoroalkane) Inhalation Aerosol MDI (metered-dose inhaler) for the treatment of asthma